NYSE - Nasdaq Real Time Price USD

Envista Holdings Corporation (NVST)

Compare
16.97 -0.25 (-1.45%)
As of 3:21 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,562,900.00
2,566,500.00
2,569,100.00
2,508,900.00
1,929,100.00
--
Cost of Revenue
1,128,800.00
1,126,000.00
1,094,300.00
1,082,400.00
874,300.00
--
Gross Profit
1,434,100.00
1,440,500.00
1,474,800.00
1,426,500.00
1,054,800.00
--
Operating Expense
1,168,300.00
1,150,700.00
1,155,600.00
1,120,300.00
1,011,300.00
--
Operating Income
265,800.00
289,800.00
319,200.00
306,200.00
43,500.00
--
Net Non Operating Interest Income Expense
-59,600.00
-63,400.00
-38,400.00
-54,100.00
-62,500.00
--
Other Income Expense
-281,500.00
-281,300.00
3,100.00
2,400.00
-1,000.00
--
Pretax Income
-75,300.00
-54,900.00
283,900.00
254,500.00
-20,000.00
--
Tax Provision
45,100.00
45,300.00
45,900.00
-9,000.00
-62,500.00
--
Net Income Common Stockholders
-120,400.00
-100,200.00
243,100.00
340,500.00
33,300.00
--
Diluted NI Available to Com Stockholders
-120,400.00
-100,200.00
243,100.00
340,500.00
33,300.00
--
Basic EPS
-0.73
-0.60
1.49
2.11
0.21
--
Diluted EPS
-0.73
-0.60
1.37
1.92
0.20
--
Basic Average Shares
168,975.00
166,900.00
162,900.00
161,200.00
159,600.00
--
Diluted Average Shares
168,975.00
166,900.00
177,600.00
177,600.00
164,100.00
--
Total Operating Income as Reported
7,500.00
31,500.00
319,200.00
306,200.00
43,500.00
--
Total Expenses
2,297,100.00
2,276,700.00
2,249,900.00
2,202,700.00
1,885,600.00
--
Net Income from Continuing & Discontinued Operation
-120,400.00
-100,200.00
243,100.00
340,500.00
33,300.00
--
Normalized Income
34,580.00
103,857.00
238,000.00
263,500.00
42,500.00
--
Interest Expense
59,600.00
63,400.00
38,400.00
54,100.00
62,500.00
--
Net Interest Income
-59,600.00
-63,400.00
-38,400.00
-54,100.00
-62,500.00
--
EBIT
-15,700.00
8,500.00
322,300.00
308,600.00
42,500.00
--
EBITDA
143,400.00
171,100.00
484,400.00
460,500.00
205,600.00
--
Reconciled Cost of Revenue
1,128,800.00
1,126,000.00
1,094,300.00
1,082,400.00
874,300.00
--
Reconciled Depreciation
159,100.00
162,600.00
162,100.00
151,900.00
163,100.00
--
Net Income from Continuing Operation Net Minority Interest
-120,400.00
-100,200.00
238,000.00
263,500.00
42,500.00
--
Total Unusual Items Excluding Goodwill
-258,300.00
-258,300.00
--
--
--
--
Total Unusual Items
-258,300.00
-258,300.00
--
--
--
--
Normalized EBITDA
401,700.00
429,400.00
484,400.00
460,500.00
205,600.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-103,320.00
-54,243.00
--
--
--
--
12/31/2019 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XRAY DENTSPLY SIRONA Inc.
25.73
+0.27%
 
STMN.SW Straumann Holding AG
107.20
-0.37%
 
STVN Stevanato Group S.p.A.
17.52
-2.94%
 
ICUI ICU Medical, Inc.
120.14
+1.38%
 
6699.HK Angelalign Technology Inc.
58.600
+0.09%
 
ANIK Anika Therapeutics, Inc.
25.82
-0.65%
 
BLCO Bausch + Lomb Corporation
14.73
-1.40%
 
ANGO AngioDynamics, Inc.
5.70
-3.23%
 
ATRC AtriCure, Inc.
21.01
+5.79%
 
BAX Baxter International Inc.
33.75
-0.47%